Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM

NCT02070315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1247

Last updated 2026-01-27

No results posted yet for this study

Summary

Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.

Conditions

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • James Trotter, MD · Baylor Health Care System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2022-04-28
Completion
2022-04-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02070315 on ClinicalTrials.gov